Partner

Won Sang LEE

Primary Industry Experience :
  • Biotechnology / Life Sciences
  • Pharmaceutical / Medical Devices / Healthcare
  • Specialized
    Practice Areas :
    Patent Prosecution, Litigation and Enforcement Activities, Counseling and Legal Opinions, Technology Transfer / Licensing

    Biography

    Won Sang Lee is a partner and co-leader of the firm’s Chemical/Pharmaceutical/Life Sciences Group. Mr. Lee has significant experience overseeing matters in every technical field related to his practice group, with particular focus on IP disputes occurring in the US, Europe, and Japan.

    Mr. Lee utilizes his experience gained from spending several years at a top IP boutique firm in Washington, D.C. to formulate client-specific strategies and provide optimized services to bring about optimized results. A registered Korean patent attorney and a U.S. attorney-at-law, Mr. Lee brings an added perspective to the services he provides to his clients, particularly in prosecution, enforcement, litigation, and opinion work.

    Mr. Lee is a frequent lecturer both domestically and in the U.S. on Korean IP issues, speaking at conferences and seminars held by various legal and industry associations around the world. He also provides the firm’s clients with industry updates based on his analysis of recent IP decisions from around the world.

    Profile

    • Bar Admissions
      • ·U.S. District Court for the Eastern District of Virginia (2003)
      • · Virginia State Bar (2002)
      • · Korean Patent Bar (1994)
    • Education
      • ·Franklin Pierce Law Center (J.D. & M.I.P., 2002)
      • · Seoul National University, Department of Molecular Biology (M.S., 1991; B.S., 1989)
      • ·
    • Experience
      • ·FirstLaw P.C. (2004~present)
      • · Associate, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., Virginia (2002~2004)
      • · Summer Associate, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., Washington, D.C. (2001)
      • · Associate, Kim, Jung & Co. (1996~1997)
      • · In-house Patent Attorney, Korea Green Cross Pharmaceutical Co. (1996)
      • · Associate, Ha & Ha (1993~1996)
    • Professional Activities
      • ·Korea Patent Attorneys Association (KPAA)
      • · Virginia State Bar (VSB)
    • Languages
      • ·Korean, English and Japanese

    INSIGHT

    FirstLaw Newsletter

    REVISIONS TO THE KIPO TRIAL SYSTEM

    September 27, 2023.

    FirstLaw Newsletter

    SUPREME COURT CLARIFIES MATERIAL TIME TO DETERMINE EQUIVALENCY TO BE TIME OF ADJUDICATION

    March 31, 2023.

    FirstLaw Newsletter

    LACK OF EXPRESS DISCLAIMER HELD TO PRECLUDE APPLICATION OF PROSECUTION HISTORY ESTOPPEL

    December 30, 2022.

    FirstLaw Newsletter

    SUPREME COURT RELAXES INVENTIVENESS STANDARD FOR CRYSTALLINE FORM INVENTIONS

    June 30, 2022.

    FirstLaw Newsletter

    COMBINATION OF PRIOR ART TECHNOLOGIES HELD INVENTIVE UPON SHOWING OF DIFFICULTY TO COMBINE THEM

    December 31, 2021.

    FirstLaw Newsletter

    SUPREME COURT RESTATES INVENTIVENESS STANDARD FOR SELECTION INVENTION

    June 30, 2021.

    FirstLaw Newsletter

    ESTOPPEL HELD APPLICABLE TO CLAIM ELEMENT IN LIGHT OF REMARKS AND COMPARATIVE DATA IN PATENT SPECIFICATION

    December 31, 2020.